Status:
COMPLETED
Effect of Rocuronium and Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children
Lead Sponsor:
Istanbul University
Collaborating Sponsors:
GAMZE PİRİNÇ ŞAŞIOĞLU
GÜNER KAYA
Conditions:
Anesthetics, Inhalation
Neuromuscular Blockade
Eligibility:
All Genders
2-10 years
Phase:
NA
Brief Summary
Sugammadex is the first selective relaxant binding agent approved to reverse certain non-depolarizing neuromuscular drugs in patients 2 years old and above. Although it has been in use over the last 1...
Detailed Description
160 participants aged between 2-10 years old and scheduled for lower urinary tract or minor abdominal surgery will be enrolled in the study. Each participant will be assigned sevoflurane (Group S) or ...
Eligibility Criteria
Inclusion
- Lower urinary tract surgery (cystoscopy, examination under general anaesthesia, circumcision etc.) and inguinal hernia surgery expected no to last more than 2 hours
- ASA I-II
Exclusion
- Liver and failure
- Upper airway infection
- Asthma
- Exposure to second hand smoke
- Kidney failure
- Obesity (BMI\> 30%)
- Rocuronium allergy
- Muscle disease (myasthenia gravis, muscular dystrophies, etc.)
- Calcium channel blocker use
- Patient or family refusal
Key Trial Info
Start Date :
December 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 19 2019
Estimated Enrollment :
148 Patients enrolled
Trial Details
Trial ID
NCT03795259
Start Date
December 28 2018
End Date
May 19 2019
Last Update
May 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Please Select, Turkey (Türkiye), 34098